↓ Skip to main content

Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term…

Overview of attention for article published in Breast Cancer Research and Treatment, February 2010
Altmetric Badge

Mentioned by

patent
3 patents

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
83 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Epidermal growth factor receptor and vascular endothelial growth factor receptor 2 are specific biomarkers in triple-negative breast cancer. Results from a controlled randomized trial with long-term follow-up
Published in
Breast Cancer Research and Treatment, February 2010
DOI 10.1007/s10549-010-0758-6
Pubmed ID
Authors

Lisa Rydén, Karin Jirström, Monica Haglund, Olle Stål, Mårten Fernö

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
Unknown 82 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 10 12%
Researcher 10 12%
Student > Bachelor 10 12%
Other 8 10%
Student > Master 8 10%
Other 17 20%
Unknown 20 24%
Readers by discipline Count As %
Medicine and Dentistry 33 40%
Biochemistry, Genetics and Molecular Biology 11 13%
Agricultural and Biological Sciences 6 7%
Chemistry 3 4%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Other 7 8%
Unknown 21 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 June 2020.
All research outputs
#7,536,586
of 22,994,508 outputs
Outputs from Breast Cancer Research and Treatment
#1,674
of 4,677 outputs
Outputs of similar age
#49,281
of 166,318 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#21
of 48 outputs
Altmetric has tracked 22,994,508 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,677 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 166,318 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.